Journal article

Choosing and sequencing novel drugs in CLL: dealing with an embarrassment of riches?

CS Tam, JF Seymour

Annals of Oncology | OXFORD UNIV PRESS | Published : 2017

DOI: 10.1093/annonc/mdx103

Citation metrics

Keywords

Science & Technology
Idelalisib
Chronic Lymphocytic-Leukemia
Regimen
Ibrutinib
Venetoclax
Fludarabine
Oncology
Life Sciences & Biomedicine
Initial Therapy
Cyclophosphamide
Rituximab